Related by context. All words. (Click for frequent words.) 83 Study Evaluating 82 Meets Primary Endpoint 81 Receives Orphan Drug Designation 81 Completes Enrollment 80 Phase IIb Trial 80 Improves Outcomes 80 Phase IIb Clinical Trial 80 Phase III Clinical Trial 80 Phase III Trial 80 Patients Treated With 79 Completes Patient Enrollment 79 Clinical Trial Results 79 Drug Candidate 79 Improves Survival 79 FDA Approvals 78 Adjunctive Therapy 78 Advanced Melanoma 78 Oral Fingolimod 78 Phase 2b Clinical Trial 78 Prolongs Survival 78 Patients Undergoing 78 Adjuvant Treatment 78 Is Well Tolerated 78 Long Term Efficacy 78 Controlled Study 78 Pivotal Trial 77 Single Dose 77 Files IND 77 Initiates Clinical Trial 77 Combination Treatment 77 Previously Treated 77 Shows Efficacy 77 Osteoporosis Drug 77 Dose Escalation 77 Phase IIa Clinical Trial 77 Demonstrates Significant 77 Phase 2a Trial 77 Submits NDA 77 Pooled Analysis 77 II Clinical Trial 77 Trial Evaluating 77 Heart Failure Patients 77 Patients Treated 77 Phase 2b Trial 77 Phase 2a Clinical Trial 77 First Patient Enrolled 77 Study Showed 77 Preclinical Data 76 Investigational Treatment 76 Study Demonstrates 76 Presents Positive 76 Granted Orphan Drug 76 FDA Okays 76 FDA Clears 76 Diabetic Patients 76 Patient Enrollment 76 Pivotal Study 76 Less Invasive 76 Dose Ranging Study 76 IND Application 76 Randomized Double Blind 76 Reduces Mortality 76 Investigational Compound 76 Pivotal Phase 76 Confirmatory Phase 76 Initiate Clinical Trial 76 Severe Sepsis 76 Protease Inhibitor 76 Initiate Phase 76 FDA Accepts 76 NDA Submission 76 Patients Receiving 76 Elderly Patients 76 Lung Cancer Trial 76 Phase Ib Clinical Trial 76 Newly Diagnosed Multiple Myeloma 76 Phase 2b Study 76 Appears Safe 76 Mylan Receives Approval 76 Clinical Evaluation 75 Proves Effective 75 Investigational Agent 75 Announces FDA Clearance 75 Slow Progression 75 Well Tolerated 75 Novel Oral 75 Receives FDA Clearance 75 Prospective Randomized 75 Hormone Refractory Prostate Cancer 75 Metastatic Prostate Cancer 75 Randomized Phase 75 Reduces Risk 75 Advanced Colorectal Cancer 75 Improve Survival 75 Osteoporosis Treatment 75 FDA Approves 75 Hypertensive Patients 75 Myeloma Patients 75 Initiates Phase II 75 Bone Metastases 75 Demonstrates Positive 75 Successfully Completes Phase 75 Antitumor Activity 75 Treatment Experienced 75 Significantly Reduces 75 Node Positive 75 Pulmonary Arterial Hypertension 75 Versus Placebo 75 Inhaled Nitric Oxide 75 Patients Suffering 75 Relapsing Multiple Sclerosis 75 Inhaled Corticosteroids 75 Initiate Phase III 75 Treatment Reduces 75 Randomized Clinical Trial 75 Treated Patients 74 Treat Anemia 74 Transdermal Patch 74 Postmenopausal Osteoporosis 74 Clinical Study 74 Presents Preclinical Data 74 HCV Protease Inhibitor 74 Disease Modifying 74 Knee Osteoarthritis 74 Epilepsy Drug 74 Rheumatoid Arthritis Patients 74 Schizophrenia Treatment 74 Monotherapy 74 Demonstrated Significant 74 Investigational Oral 74 Lupus Drug 74 Phase 1b Clinical Trial 74 Pivotal Clinical Trial 74 Initiates Phase III 74 Proven Effective 74 Lung Cancer Drug 74 Effectively Treats 74 Shows Promise Against 74 Investigational Drug 74 Pivotal Phase III 74 Complicated Skin 74 Metastatic Melanoma 74 Expanded Indication 74 Treatment Naïve 74 Drug Shows Promise 74 Receives Approvable Letter 74 Shows Promising 74 Pharmacokinetic Study 74 Demonstrates Sustained 74 Clinical Study Shows 74 Oral Calcitonin 74 Novel Compound 74 Adjuvant Chemotherapy 74 FDA Approves Drug 74 Chronic Hepatitis C 74 Artery Disease 74 Renal Impairment 74 Initiates Enrollment 74 Clinical Efficacy 74 Phase III Trials 74 Diabetic Foot Ulcer 74 Anti Tumor Activity 74 Ischemic Stroke 74 Adjuvant Therapy 74 Initiates Clinical 74 Kidney Transplant Patients 74 Schizophrenia Drug 73 Prostate Cancer Patients 73 Nicotine Vaccine 73 Improved Survival 73 Commences Phase 73 Relapsed Refractory 73 Asthma Treatment 73 Cholesterol Lowering Drug 73 Significantly Reduced 73 Successfully Treated 73 Controlled Trial 73 Unfractionated Heparin 73 ORLive Presents 73 Fungal Infections 73 Relapsed Multiple Myeloma 73 Arthritis Drug 73 Treating Heart Failure 73 Treating Chronic 73 Demonstrates Potential 73 Pediatric Patients 73 Castration Resistant Prostate Cancer 73 Hemodialysis Patients 73 IND Filing 73 Bosutinib 73 Significantly Improves 73 Statin Therapy 73 Combination REOLYSIN R 73 Significantly Improved 73 Pivotal Trials 73 Hormone Receptor Positive 73 Combo Therapy 73 Generic Versions 73 Left Ventricular 73 Enrolls First 73 Metastatic Colorectal Cancer 73 Teva Provides Update 73 Initiates Phase 73 Meta Analysis 73 Reduces Pain 73 Achieves Primary Endpoint 73 Clinical Outcome 73 Novel Therapeutic 73 HER2 Positive 73 Generic Version 73 Prostate Cancer Vaccine 73 Vaccine Adjuvant 73 Randomized Trials 73 First Patient Dosed 73 Randomized Clinical Trials 73 Blood Pressure Drug 73 Lowers Risk 73 Survival Benefit 73 Double Blind Placebo 73 Novel Antibiotic 73 Postmenopausal Women 73 Subgroup Analysis 73 Statistically Significant 73 Phase IIa Trial 73 Breast Cancer Recurrence 73 Reduced Risk 73 JAK Inhibitor 73 Efficacy Trial 73 Begins Dosing 73 Efficacy Results 73 Successfully Treats 73 Files Investigational 72 Study Validates 72 Data Suggest 72 Tyrosine Kinase Inhibitor 72 Osteoporosis Drugs 72 NICE Recommends 72 ST Elevation Myocardial 72 Acute Ischemic Stroke 72 Proves Successful 72 First Patient Treated 72 Advanced Renal Cell 72 Treatment Resistant 72 Mouse Model 72 Receptor Agonist 72 Multiple Myeloma Patients 72 Estrogen Therapy 72 Poorly Controlled 72 Chronic Hepatitis B 72 Migraine Drug 72 Desvenlafaxine Succinate 72 Randomized Phase II 72 Resistant Hypertension 72 Mg Usa 72 Blood Thinner 72 Present Preclinical Data 72 Slows Progression 72 Phase III Pivotal 72 Neoadjuvant Chemotherapy 72 Gout Drug 72 Psoriasis Drug 72 Cell Transplants 72 Demonstrates Efficacy 72 Prostate Cancer Treatment 72 Orally Active 72 PRN FDA Approves 72 Immunomedics Announces 72 Renal Cell Carcinoma 72 Intravitreal 72 Stent Restenosis 72 Cholesterol Drug 72 Drug Fails 72 Benign Prostatic Hyperplasia 72 Therapeutic Efficacy 72 Confirms Efficacy 72 Initiates Clinical Trials 72 HER2 Positive Breast Cancer 72 Peripheral Arterial 72 Plus Ribavirin 72 Spectrum Pharmaceuticals Announces 72 Advanced Prostate Cancer 72 ACE Inhibitors 72 Rheumatoid Arthritis Drug 72 Treatment Naive Patients 72 Randomized Study 72 Plaque Psoriasis 72 Randomized Controlled Trials 72 Levels Linked 72 Obese Patients 72 Autologous Stem Cell Transplantation 72 Tumor Growth 72 Novel Treatments 72 Infected Patients 72 Stem Cell Treatment 72 Predict Risk 72 JAK2 Inhibitor 72 Heart Transplant Recipients 72 Treatment Regimen 72 Novel Inhibitor 72 Medoxomil 72 Mg Uk 72 Develop Novel 72 Inhaled Insulin 72 FDA Clearance 72 Receives Positive Opinion 72 Hsp# Inhibitor 72 Intravenous Formulation 72 Fracture Risk 72 Randomized Double blind 72 Peginterferon 72 Rotavirus Vaccine 72 Seasonal Influenza Vaccine 72 Hepatitis B Vaccine 72 Test Detects 71 Fondaparinux 71 Initiated Phase 71 Sustained Efficacy 71 Recurrent Ovarian Cancer 71 Receives Milestone Payment 71 Prevent Stroke 71 Anticancer Agent 71 Initiates Phase 2b 71 Diabetic Nephropathy 71 Placebo Controlled 71 Low Dose 71 Effective Than 71 Partial Onset Seizures 71 Myelodysplastic Syndromes 71 Molecular Diagnostic Test 71 Demonstrates Potent 71 Therapy Reduces 71 Shows Promise 71 Refractory Hodgkin Lymphoma 71 Antiviral Activity 71 Patients Enrolled 71 Taro Receives 71 Beta Blocker 71 Vascular Grafts 71 Combination Therapy 71 Gets FDA Clearance 71 Shows Statistically Significant 71 Guidelines Issued 71 Dose Ranging 71 Venous Thromboembolism 71 Liver Metastases 71 Prolongs Life 71 Shingles Vaccine 71 See CLINICAL PHARMACOLOGY 71 Overactive Bladder 71 Radical Prostatectomy 71 Non Invasive Treatment 71 Anti Tumor 71 Anticancer Drug 71 Percutaneous Tibial Nerve Stimulation 71 FDA APPROVES 71 Bone Marrow Cells 71 Placebo Controlled Study 71 Cutaneous T 71 Cholesterol Drugs 71 Advanced Solid Tumors 71 Enlarged Prostate 71 Phase III Clinical Trials 71 Testosterone Gel 71 Anti Inflammatory Drug 71 Oral Cladribine 71 Diabetic Neuropathy 71 REMINDER ORLive Presents 71 Platelet Inhibition 71 Study Shows Promise 71 Extended Release 71 Submits Biologics License Application 71 Cervical Cancer Vaccine 71 Abciximab 71 Humanized Anti 71 Brain Metastases 71 Glatiramer Acetate 71 Protein Linked 71 Increased Mortality 71 Increased Risk 71 TO AVOID PREGNANCY WHILE 71 Smallpox Vaccine 71 phenyl salicylate methylene blue 71 Advanced Ovarian Cancer 71 Previously Untreated 71 Metastatic Renal Cell Carcinoma 71 Drug Combo 71 Chemoradiation 71 Prophylactic Treatment 71 Antipsychotic Drug 71 Increases Risk 71 Pharmacokinetics PK 71 Novel Compounds 71 Inhibits 71 Acute Myocardial Infarction 71 Lung Cancer Patients 71 Treatment Naïve Patients 71 Tezampanel 71 Arterial Disease 71 Submits Application 70 Implantable Device 70 Showed Significant 70 Kinase Inhibitor 70 Stent Implantation 70 Androgen Deprivation Therapy 70 Treatment Naive 70 Achieves Milestone 70 Osteoarthritis Patients 70 Treat Heart Failure 70 Drug Eluting 70 Dose Response 70 Carotid Stent 70 FDA Panel Recommends 70 Coronary Arteries 70 Bare Metal Stents 70 Study Confirms 70 Total Knee Arthroplasty 70 Migraine Treatment 70 Kidney Function 70 vapreotide acetate 70 Hepatitis C Genotype 70 Commence Phase 70 Recurrent Breast Cancer 70 Study Shows Benefits 70 Seasonal Allergic Rhinitis 70 Cardiovascular Events 70 AnaSpec Introduces 70 Pramlintide 70 Robotic Assisted 70 Fast Track Status 70 Genes Linked 70 Statin Drugs 70 Patient Enrolment 70 Lupus Nephritis 70 Balloon Angioplasty 70 Randomized Evaluation 70 Induction Therapy 70 Holds Promise 70 Newly Diagnosed 70 Cardiac Resynchronization 70 Clostridium difficile Infection 70 Unstable Angina 70 Improve Outcomes 70 Intracranial Aneurysms 70 Parathyroid Hormone 70 Secondary Hyperparathyroidism 70 Relapsing Remitting Multiple Sclerosis 70 benzoic acid hyoscyamine sulfate 70 Minimally Invasive Treatment 70 Receives Orphan Drug 70 Study Casts Doubt 70 Embolic Protection 70 Zoledronic Acid 70 Insulin Pen 70 Endovascular Treatment 70 Launches Generic Version 70 Post Operative 70 Peginterferon Alfa 2a 70 Liver Failure 70 Genes Predict 70 Breast Cancer Treatment 70 Cocaine Addiction 70 Therapy Improves 70 RNAi Therapeutic 70 Anticancer Activity 70 Antipsychotic Drugs 70 Sirolimus Eluting Stent 70 Collaborators Present 70 #-# Full Text 70 Gene Linked 70 Gene Mutation 70 Refractory Angina 70 Study Evaluates 70 Receives Fast Track 70 Randomized Double Blind Placebo 70 Device Helps 70 Weight Loss Drug 70 Announces Tentative Approval 70 Carboplatin Paclitaxel 70 Sagent Pharmaceuticals Announces 70 Hydrochlorothiazide Tablets 70 Beneficial Effects 70 Testosterone Patch 70 Hematological Cancers 70 Breast Cancer Patients 70 Topline Results 70 Ovarian Cancer Patients 70 Implantable Cardioverter Defibrillator 70 Phase III Pivotal Trial 70 Melphalan 70 Carotid Stenting 70 Cholesterol Lowering 70 Endometrial Ablation 70 Preclinical Study 70 Replacement Therapy 70 Transdermal System 70 Oral Insulin 70 Radiofrequency Ablation 70 R lenalidomide 70 Prospective Multicenter 70 Gene Variant 70 Anti Clotting Drug 70 Kidney Transplant Recipients 70 Chronic Renal Failure 70 FDA Warns 70 Hormone Therapy 70 Left Ventricular Dysfunction 70 Telaprevir VX 70 Cypher Sirolimus 70 Newly Diagnosed Patients 70 Naive Patients 70 Guidelines Recommend 70 Laryngeal Cancer 70 Electrical Stimulation 69 Hematological Malignancies 69 Cardiovascular Outcomes 69 Recombinant Human 69 Shown Effective 69 Skeletal Muscle 69 Stent Placement 69 Menopausal Symptoms 69 Proc Am Soc 69 Erectile Dysfunction Drug 69 Tumor Response 69 Contrast Agent 69 Interferon Gamma 69 Personalized Immunotherapy 69 ST Segment Elevation 69 Announce License Agreement 69 Eur J 69 Detection Device 69 Milestone Payment From 69 Oral Laquinimod 69 Antibody Drug Conjugate 69 Obesity Linked 69 Localized Prostate Cancer 69 Being Studied 69 Symptom Relief 69 Ranolazine 69 Placebo Controlled Trial 69 Sleep Disturbances 69 Soft Tissue Sarcoma 69 Further Validates 69 Aortic Valve Replacement 69 Drug Eluting Coronary Stent 69 Regenerative Cells 69 Potentially Fatal 69 Non Invasive 69 Preclinical Models 69 Dry Powder Inhalers 69 Bivalirudin 69 Hernia Repair 69 Demonstrate Significant 69 Drug Prevents 69 Submits Supplemental 69 Atypical Antipsychotic 69 Tissue Engineered 69 pralatrexate injection folate analogue 69 Presents Positive Preclinical 69 Advanced Gastric Cancer 69 Multicenter Randomized Double 69 Boosts Survival 69 Intra Arterial 69 Cancer Treatments 69 Attenuates 69 Non Responders 69 Acute Attacks 69 Cardiogenic Shock 69 J Am Coll 69 Drug Coated Stents 69 Fewer Side Effects 69 Surgical Mesh 69 Patient Treated 69 Aortic Valve 69 Sapacitabine 69 Helps Predict 69 Patent Covering 69 TM Drug Eluting 69 Polymerase Inhibitor 69 Clot Busting 69 Genetic Tests 69 Tiotropium 69 Disease Progression 69 Pain Relievers 69 Microwave Ablation System 69 IN PATIENTS WITH 69 Primary Hypercholesterolemia 69 Critically Ill Patients 69 Vildagliptin 69 Lung Tumors 69 Bipolar Depression 69 Male Contraceptive 69 IIa Clinical Trial 69 Metabolic Efficiency 69 Tolerability 69 Ozarelix 69 Topical Treatment 69 Renal Function 69 Oral Spray 69 Systemic Sclerosis 69 Colorectal Cancer Patients 69 Immune Cells 69 SABER ™ 69 Anticoagulant 69 Monoclonal Antibody 69 acute peptic ulcer 69 C1 Inhibitor 69 Pain Medications 69 Glufosfamide 69 Helps Identify 69 Resubmission 69 Gene Variants 69 Study Indicates 69 Dupuytren Contracture 69 Presents Preclinical 69 Bare Metal Stent 69 Blood Cancers 69 Hepatocellular Carcinoma 69 Dose Escalation Study 69 Prove Effective 69 Recommends Approval 69 Aurora Kinase 69 Minimally Invasive Procedure 69 Aneurysm Repair 69 Improves Quality 69 Biomarker Study 69 Improve Diagnosis 69 Novel Method 69 Higher Doses 69 Ventricular Arrhythmias 69 Gastric Cancer 69 Safinamide 69 PDUFA Date 69 Randomized Controlled Trial 69 Hospital Acquired Pneumonia 69 Randomized Placebo Controlled Trial 69 Elagolix 69 Demonstrates Statistically Significant 69 Severe Asthma 69 Ondansetron Injection USP 69 Artificial Skin 69 PHASE III 69 Demonstrates Long Term 69 Antidepressants Linked 69 Inhalation Aerosol 69 Positive Opinion 69 Inflammatory Markers 69 Visceral Fat 69 Spinal Fusion 69 Brain Atrophy 68 Anemia Drug 68 Inflammatory Arthritis 68 Infarct 68 Fixed Dose 68 dependent kinase inhibitor 68 Crofelemer budesonide foam 68 Vicriviroc 68 Licenses Novel 68 Progenitor Cells 68 Dry Powder Inhaler 68 Mitral Valve Repair 68 Therapeutic Antibody 68 Diagnostic Tests 68 Contrast Agents 68 Intravascular 68 Myocardial Ischemia 68 Bazedoxifene 68 Clinical Trial Data 68 Completes Patient Enrolment 68 Nebulized 68 Atypical Hemolytic Uremic Syndrome 68 Inhaled Liposomal Ciprofloxacin 68 Pneumococcal Vaccine 68 Long Term Outcomes 68 Orthostatic Hypotension 68 Hepatitis C Patients 68 Study Proves 68 Recurrent Glioblastoma 68 Novel Mechanism 68 Patent Issued 68 Announces Initiation 68 Chronic Heart Failure 68 Antiviral Therapy 68 Tumor Targeting 68 topical gel formulation 68 Help Detect 68 Pharmaceuticals Initiates 68 Double Blind Randomized 68 Milestone Payment 68 Circulating Tumor Cells 68 Drug Coated Stent 68 RNAi Therapeutics 68 Lung Cancer Survival 68 Perifosine KRX 68 Avian Flu Vaccine 68 Carotid Artery Stenting 68 Paclitaxel Eluting 68 Cognitive Function 68 Sirolimus Eluting 68 Mycophenolate Mofetil 68 Arthritis Sufferers 68 By JENNIFER LEARN 68 Premature Infants 68 Cyclophosphamide 68 Testosterone MDTS ® 68 Vascular Disrupting Agent 68 Kidney Transplants 68 Accelerated Partial Breast Irradiation 68 Cardiac Function 68 Malaria Vaccine 68 Valve Replacement 68 Endometrial Cancer 68 Renal Cancer 68 Anti Nausea 68 Reveals Positive 68 topically applied SEPA 68 Chemotherapeutic Agents 68 Second Pivotal Phase 68 Rigel R# 68 Remission Maintenance 68 Eluting Stent 68 Randomised Controlled Trial 68 TRANSDUR ™ 68 Invasive Breast Cancer 68 Ebola Vaccine 68 FDA Approval 68 Anti CD# Antibody 68 Solid Tumors 68 Mouse Models 68 Cardiopulmonary Bypass 68 Hepatitis C Treatment 68 VIVITROL ® 68 Randomized Controlled 68 Cognitive Impairment 68 Initiates Dosing 68 Pafuramidine 68 PROMUS TM 68 Submits Response 68 Epoetin Alfa 68 Efficacious 68 Pulmonary Artery 68 Study Compares 68 Receives CE Marking 68 Synthetic Peptide 68 Hypercholesterolemia 68 Crit Rev 68 Predict Response 68 Vaginal Gel 68 Acute Migraine 68 VIVUS Announces 68 Antiviral Drugs 68 Weight Loss Pill 68 Oral Formulation 68 Tablet Formulation 68 Antiepileptic Drug 68 Vaccine Prevents 68 Relieves Pain 68 Radiotherapy Treatment 68 Pre Cancerous 68 Prostate Biopsy 68 Lowering Blood Pressure 68 Hip Fractures 68 Anti Inflammatory 68 TRANSDUR ® 68 Transplant Patients 68 Cardiac Resynchronization Therapy 68 Dementia Patients 68 EnteroMedics proprietary neuroblocking technology 68 Prognostic Significance 68 Premenopausal Women 68 Unresectable 68 Carbidopa Levodopa 68 Androgen Independent 68 Insulin Resistance 68 Bone Grafting 68 Renal Artery 68 Interferon beta 1a 68 Bucindolol Based 68 Chronic Sinusitis 68 Levoleucovorin 68 Acute Coronary Syndromes 68 Radiation Treatment 68 Combination Clinical Trial 68 Liposomal 68 Often Misdiagnosed 68 Blood Clots 68 Endovascular Repair 68 Skin Lesions 68 Diabetic Kidney Disease 68 Antigen Specific 68 Therapy Shows Promise 68 HDAC Inhibitor 68 Nesiritide 68 Tuberculosis Vaccine 68 Sustained Reduction 68 Lowers Blood Pressure 68 Aliskiren 68 Epilepsy Drugs 68 Vitrasert R 68 Pivotal Phase II 68 NAVISTAR R 68 CT Angiography 68 include Phenoptin TM 68 Receives SFDA Approval 68 Ovitrelle R Serostim 68 Clinical Trial 68 Blind Placebo Controlled Trial 68 Risk Stratification 68 Urine Test 68 Sustained Release 68 Vaccine Adjuvants 68 Bevacizumab 68 Enrolling Patients 68 Aggressive Prostate Cancer 68 CDC Recommends 68 Complete Remission 68 Drug Eluting Stent 68 Systemic Delivery 68 Commonly Prescribed 68 Treating Depression 68 Adjunctive 68 Physician Insights 68 Eases Pain 68 Drug Resistant 68 Files Patent Application 68 Sipuleucel T 68 Percutaneous Coronary Intervention 68 Controlled Clinical Trial 68 Supplemental Biologics License Application 68 Ovarian Cancer Treatment 68 Reduced Incidence 68 Myoblast 68 Heartburn Drugs 68 Help Smokers Quit 68 Fast Tracked 68 Inflammatory Disease 68 Prostate Surgery 68 Treatment Shows Promise 68 Observational Study 68 Heart Stents 68 Paroxysmal Atrial Fibrillation 68 Atypical Antipsychotics 68 Nucleoside 68 Newly Diagnosed Breast Cancer 68 Hedgehog Pathway 68 Obtains FDA 67 Eszopiclone 67 Predict Dementia 67 novel orally inhaled 67 TNF Blockers 67 Multicenter Randomized 67 5q MDS 67 Zorbtive TM 67 Diuretic 67 Helps Prevent 67 Calcium Supplements 67 Boxed Warnings 67 Osteoarthritis Pain 67 Phospholipase A2 67 Influenza Vaccine Production 67 Bone Marrow Transplants 67 Balloon Catheter 67 Septic Shock 67 Maleate 67 Malignant Glioma 67 J Shoulder Elbow 67 Excessive Sweating 67 PROMUS R 67 Proton Pump Inhibitor 67 Embolic 67 Advanced Pancreatic Cancer 67 External Beam 67 Beta Blockers 67 Drug Eluting Stents 67 Study Reinforces 67 Patient Outcomes 67 VIVUS Qnexa 67 Earns Milestone Payment 67 Clinically Proven 67 Smoking Linked 67 INDUSTRY ASSESSMENTS 67 Subtypes 67 Colorectal Adenomas 67 Vaccine Candidate 67 Poster Presentations 67 Catheter Ablation 67 Diamyd Medical Diamyd 67 Stent Coating 67 Commercialize Novel 67 Blocked Arteries 67 Diabetic Neuropathic Pain 67 Magnetic Nanoparticles 67 dasatinib Sprycel ® 67 Lipid Lowering 67 Chemotherapy Regimen 67 FDA Warns Against 67 Receives Marketing Authorization 67 selective A2A adenosine receptor 67 Left Ventricular Hypertrophy 67 Hepatic Encephalopathy 67 Virus Linked 67 Bepreve TM 67 Successfully Tested 67 Sign Licensing Agreement 67 Carotid Endarterectomy 67 Contrast Enhanced 67 Urinary Incontinence 67 Capsules CII 67 Vertebral Compression Fractures 67 Begins Shipment 67 Adenoma 67 Commonly Used 67 Cell Lymphoma 67 Multiple Ascending Dose 67 Serious Infections 67 Cervical Dysplasia 67 bone marrow reticulin deposition 67 Xenografts 67 Prognostic Value 67 Clinical Trial Enrollment 67 5 Fluorouracil 67 MEK Inhibitor 67 Autoimmune Diseases 67 Completes Dosing 67 Who Underwent 67 brand ciclesonide HFA 67 urethral bulking agent 67 Alternative Treatments 67 Announce Collaboration Agreement 67 PEGylated Fab fragment 67 LENALIDOMIDE 67 Suppresses 67 Surgical Procedures 67 Pancreatic Adenocarcinoma 67 Antipsychotic 67 Acne Drug 67 Submits IND 67 Stable Angina 67 ARIXTRA R 67 Gene Variation 67 Uterine Fibroid Embolization 67 Reports Preclinical Data 67 Could Detect 67 Imaging Technique 67 Silicone Breast Implants 67 Safety Tolerability 67 SPRYCEL ® 67 ALN HPN 67 Blood Pressure Drugs 67 Antithrombin 67 Surgery Performed 67 Reduce Risk 67 Vertebral Fracture 67 Gene Therapy Trial 67 Successfully Completed 67 Help Predict 67 R Saizen R 67 Deep Venous Thrombosis 67 Pegylated Liposomal Doxorubicin 67 Dialysis Patients 67 Therapy Evaluation 67 Inhalation Solution 67 J Clin 67 Degarelix 67 Dual Antiplatelet Therapy 67 Adverse Outcomes 67 k Clearance 67 Platinol ® 67 Strongly Linked 67 Ultrasound Guided 67 Interferon Alpha 67 CYPHER R Sirolimus Eluting 67 Quadrivalent 67 Posaconazole 67 Transdermal Delivery 67 Announces Publication 67 Allogeneic 67 Surgical Treatment 67 Glaucoma Treatment 67 Elevated Levels 67 BioSante Pharmaceuticals Announces 67 Begin Clinical Trials 67 ® lenalidomide 67 moderate hepatic impairment 67 Immunosuppression 67 Could Save Lives 67 Roche Boniva 67 Chemotherapy Induced Anemia 67 Small Molecule 67 Postmenopausal 67 dual endothelin receptor antagonist 67 Angiotensin Converting Enzyme 67 MKC# 67 Heart Failure Therapy 67 Therapeutic Vaccine 67 Late Breaker 67 Universal Flu Vaccine 67 Chronic Myeloid Leukemia 67 Bioresorbable 67 Immune Responses